Sucralfate (lat. sucralfātum) is a drug for the treatment of stomach and duodenal ulcers in powder form, produced by the largest Austrian pharmaceutical company G. L. Pharma.”
Sucralf is an aluminum hydroxide-based antacid. Sucralf is active against gastroesophageal reflux and gastric ulcers. After taking Suklf orally, its gastro-acid activity persists for 5-6 hours. The components of the drug quickly accumulate in insoluble peptones of the stomach. Under the action of the enzyme pepsin, acidic algin is released, which forms basic salts. They are included in the protective mucous film of the stomach and have a longer protective effect. Reduces heartburn, dyspepsia and pain due to hyperacidity of the stomach. The antacid effect appears later, so the first effect may be felt as a weakening of symptoms and occurs mainly after taking the second portion of the suspension. According to the instructions of the drug, according to the annotation, this remedy for protecting the stomach has high clinical effectiveness. Digestive system. The drug reduces irritation of the gastric mucosa, reduces acidity, ammonia formation, improves digestion processes